The CB1 cannabinoid receptor C-terminus regulates receptor desensitization in autaptic hippocampal neurones.
OBJECTIVE
The cannabinoid CB(1) receptor is the chief mediator of the CNS effects of cannabinoids. In cell culture model systems, CB(1) receptors both desensitize and internalize on activation. Previous work suggests that the extreme carboxy-terminus of this receptor regulates internalization via phosphorylation of residues clustered within this region. Mutational analysis of the carboxy-terminus of CB(1) receptors has demonstrated that the last six serine/threonine residues are necessary for agonist-induced internalization. However, the structural determinants of CB(1) receptor internalization are also dependent on the local cellular environment. The importance of cell context on CB(1) receptor function calls for an investigation of the functional roles of these residues in neurones.


METHODS
To determine the structural requirements of CB(1) internalization in neurones, we evaluated the signalling properties of carboxy-terminal mutated CB(1) receptors expressed in cultured autaptic hippocampal neurones, using electrophysiological methods.


RESULTS
CB(1) receptors transfected into CB(1) knockout neurones signalled and desensitized as did wild-type neurones, allowing us to test specific CB(1) receptor mutations. Deletion of the last 13 residues yielded a CB(1) receptor that inhibited excitatory postsynaptic currents but did not desensitize. Furthermore, mutation of the final six serine and threonine residues to alanines resulted in a non-desensitizing receptor. In contrast, CB(1) receptors lacking residues 419-460, leaving the last 14 residues intact, did desensitize.


CONCLUSIONS
The distal thirteen residues of CB(1) receptors are crucial for their desensitization in cultured neurones. Furthermore, this desensitization is likely to follow phosphorylation of serines and threonines within this region.


BACKGROUND
This article is part of a themed section on Cannabinoids in Biology and Medicine. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue-8. To view Part I of Cannabinoids in Biology and Medicine visit http://dx.doi.org/10.1111/bph.2011.163.issue-7.
Department of Psychological and Brain Sciences, Gill Center for Biomolecular Science, Indiana University, Bloomington, IN 47405, USA. straiker@indiana.edu
Alex
A
Straiker
Jim
J
Wager-Miller
Ken
K
Mackie
D000818:Animals; D002478:Cells, Cultured; D006624:Hippocampus / Q000166:cytology / Q000502:physiology; D051379:Mice; D009154:Mutation; D009474:Neurons / Q000502:physiology*; D043884:Receptor, Cannabinoid, CB1 / Q000737:chemistry* / Q000502:physiology*
D043884:Receptor, Cannabinoid, CB1